Presentation1
description
Transcript of Presentation1
![Page 1: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/1.jpg)
Liposome: Novel Drug Delivery SystemLiposome: Novel Drug Delivery System
Jignesh PatelJignesh Patel M. Pharm.(sem-3)M. Pharm.(sem-3)
NPC,visnagarNPC,visnagar
![Page 2: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/2.jpg)
Lipids, along with proteins and nucleic acids, are essential biomolecules for the structure and function of living matter
![Page 3: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/3.jpg)
Liposomes are spherical self-closed structures, composed of curved lipid bilayers, which enclose part of the surrounding solvent into their interior. The size of a liposome ranges from some 20 nm up to severalmicrometers and they may be composed of one or several concentric membranes, each with a thickness of about 4 nm.
Liposomes possess unique properties owing to the amphiphilic character of the lipids, which make them suitable for drug delivery.
Formation of such a typical structural configuration is attributed to the amphiphilic character of phospholipids. When the letter are dispersed in excess of an aqueous phase, hydration of the polar head groups of the lipid results in a heterogeneous mixture of closed structures.
What is a liposome?What is a liposome?
![Page 4: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/4.jpg)
What is a liposome?What is a liposome?
– Spherical vesicles with a phospholipid bilayerSpherical vesicles with a phospholipid bilayer
Hydrophilic
Hydrophobic
![Page 5: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/5.jpg)
FundamentalFundamental properties: properties:
1. Size:1. Size: SUV: Small unilamellar vesicles 0.02-0.05 µµ LUV: Large unilamellar vesicles 0.1-0.5 µµ MLV: Multilamellar vesicles 1.0- >10 µµ
2. Fluidity:2. Fluidity:
3. Surface properties:3. Surface properties:
![Page 6: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/6.jpg)
Size determined by methods:Size determined by methods:
Sonication: SUV Smaller than 100 nm diameterExtrusion: LUV (Size depends on the filters) 100 nm—1 µm diameterEvaporation: MUV Larger than 1 µm diameter
![Page 7: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/7.jpg)
Materials used for preparation:Materials used for preparation:
Natural PhospholipidsNatural Phospholipids Synthetic PhospholipidsSynthetic Phospholipids SphingolipidsSphingolipids SteroidsSteroids Polymeric materialsPolymeric materials Charge lipidsCharge lipids
![Page 8: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/8.jpg)
Phospholipids:Phospholipids:Polar Head Groups
Three carbon glycerol
![Page 9: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/9.jpg)
Each phospholipidEach phospholipidincludesincludes aa polar polar region: region:
glycerolglycerol, , carbonylcarbonyl of of fatty acids, fatty acids, PPii, & the , & the polar head group (polar head group (XX))
2 2 non-polarnon-polar hydrocarbon hydrocarbon tails of fatty acids (tails of fatty acids (RR11, , RR22). ).
Such an Such an amphipathicamphipathic lipid lipidmay be represented as atmay be represented as atright.right.
O P O
O
O
H2C
CH
H2C
OCR1
O O C
O
R2
X
glycerophospholipid
3D picture of a Phospholipid
![Page 10: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/10.jpg)
PreparationPreparation of liposomes:of liposomes:
![Page 11: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/11.jpg)
Selection of bilayer component is imp from toxicity as well as shelf life Selection of bilayer component is imp from toxicity as well as shelf life optimization point of view.optimization point of view.
Common process steps for liposome formulation:Common process steps for liposome formulation:
- Bilayer components are mixed in a volatile organic solvent or Bilayer components are mixed in a volatile organic solvent or solvent mixtures (eg. Chloroform, ether, EtOH, or combination solvent mixtures (eg. Chloroform, ether, EtOH, or combination of these)of these)
- Cholesterol upto 40-50 mol % is included to provide greater Cholesterol upto 40-50 mol % is included to provide greater stability in biological fluids.stability in biological fluids.
- A charged species may be added (5-20%) to prevent A charged species may be added (5-20%) to prevent aggregation. (natural acidic phospholipids eg PS, PG, PI, PA, aggregation. (natural acidic phospholipids eg PS, PG, PI, PA, etc)etc)
- Small amt of antioxidants such as aplha-tocopherol are included Small amt of antioxidants such as aplha-tocopherol are included when polyunsaturated natural lipids are used.when polyunsaturated natural lipids are used.
- Once a suitable solution of the lipid component is made, the Once a suitable solution of the lipid component is made, the mixture may be filtered to remove minor insoluble components mixture may be filtered to remove minor insoluble components or ultra filtered to lower pyrogens.or ultra filtered to lower pyrogens.
- The solvent is subsequently removed under conditions The solvent is subsequently removed under conditions (Pressure and Temp) that ensure no phase separations of the (Pressure and Temp) that ensure no phase separations of the component of the mixture take place.component of the mixture take place.
![Page 12: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/12.jpg)
Preparation of lipid for hydration: Preparation of lipid for hydration:
![Page 13: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/13.jpg)
Methods to check the Methods to check the morphology of liposomes:morphology of liposomes:
Freeze-fracture electron microscope Freeze-fracture electron microscope (FFEM) or electron microscope (EM) (FFEM) or electron microscope (EM)
Light scattering (LS)Light scattering (LS)
![Page 14: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/14.jpg)
Methods to control vesicle Methods to control vesicle size of liposomes:size of liposomes:
CentrifugationCentrifugation Size-exclusion chromatographySize-exclusion chromatography HomogenizationHomogenization ExtrusionExtrusion
![Page 15: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/15.jpg)
CharacterizationCharacterization of liposomes:of liposomes:
1. Physical Parameters:1. Physical Parameters: SizeSize Number of LamellaeNumber of Lamellae ChargeCharge Bilayer fluidityBilayer fluidity Encapsulated volumeEncapsulated volume Drug ReleaseDrug Release Phase behavior Phase behavior
![Page 16: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/16.jpg)
2. Chemical Parameters:2. Chemical Parameters:
Quantitative determination of phospholipidQuantitative determination of phospholipid
Phospholipid hydrolysis Phospholipid hydrolysis
Phospholipid analysisPhospholipid analysis
Cholesterol analysisCholesterol analysis
![Page 17: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/17.jpg)
Classes of liposomes:Classes of liposomes:Conventional Long circulating
Immuno Cationic
![Page 18: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/18.jpg)
ModesModes of liposome/cell of liposome/cell interaction:interaction:
Adsorption Endocytosis
Fusion Lipid transfer
![Page 19: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/19.jpg)
Uses of liposomes:Uses of liposomes:Chelation therapy for treatment of heavy metal
poisoning
Enzyme replacement
Diagnostic imaging of tumors
Study of membranes
Cosmetics
Drug Delivery
![Page 20: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/20.jpg)
WhyWhy use liposomes in use liposomes in drug delivery?drug delivery?
Inactive: Unmodified liposomes gather in specific tissue
Active: alter liposome surface with ligand (antibodies, enzymes, protein A, sugars)
Directly to site
Physical: temperature or pH sensitive liposomes
Drug targeting
![Page 21: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/21.jpg)
ProtectionDecrease harmful side effects
Pharmokinetics - efficacy and toxicityChanges the absorbance and biodistribution
Change where drug accumulates in the body
Protects drug
Deliver drug in desired formMultidrug resistance
Why use liposomes in Why use liposomes in drug delivery?drug delivery?
![Page 22: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/22.jpg)
ReleaseAffect the time in which the drug is released
Prolong time -increase duration of action and decrease administration
Dependent on drug and liposome properties Liposome composition, pH and osmotic gradient, and
environment
Why use liposomes in Why use liposomes in drug delivery?drug delivery?
![Page 23: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/23.jpg)
Liposomes help improve:Liposomes help improve:Therapeutic indexRapid metabolismUnfavorable pharmokineticsLow solubilityLack of stabilityIrritation
![Page 24: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/24.jpg)
Custom design:Custom design:
Lipid contentSize
Surface charge
Method of preparation
![Page 25: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/25.jpg)
CurrentCurrent liposomal drug liposomal drug preparations:preparations:
Type of Agents ExamplesAnticancer Drugs
Anti bacterial
AntiviralDNA materialEnzymes
RadionuclideFungicidesVaccines Malaria merozoite, Malaria sporozoite
Hepatitis B antigen, Rabies virus glycoprotein
Amphotericin BIn-111*, Tc-99m
Hexosaminidase A Glucocerebrosidase, Peroxidase
Duanorubicin, Doxorubicin, Epirubicin Methotrexate, Cisplatin*, CytarabinTriclosan, Clindamycin hydrochloride, Ampicillin, peperacillin, rifamicinAZTcDNA - CFTR
![Page 26: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/26.jpg)
No decrease in effectiveness of drug against fungi
LiposomalLiposomal formulation of AmB:formulation of AmB:
Decrease in toxicity
Exact Mechanism of liposomes not understood
Cholesterol - only few %moles
Phospholipid: AmB ratio
DiffusionLipid transfer
AmB
Lipid
![Page 27: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/27.jpg)
Problems with liposomal Problems with liposomal preparations of drugs:preparations of drugs:
Cost Fungizone $40.58 Amphotec $2334
Doxil $1200 per treatment, twice the cost of normal protocol of chemotherapy and drugs
Lack long term stability (short shelf life)
Freeze dry and pH adjustment
Low “Pay Load” - poor encapsulation
Physical and chemical instability
Polar drugs and drugs without opposite charge
Modifications
![Page 28: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/28.jpg)
Possibility of new side effects
ProblemsProblems continuedcontinued
Efficacy
![Page 29: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/29.jpg)
Studies with insulin show that liposomes may be an effective way to package proteins and peptides for use
Clinical Trials for several liposomal formulations More studies on the manipulation of liposomes
FutureFuture
![Page 30: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/30.jpg)
JournalsAllen, Theresa M. "Liposomal Drug Formulations: Rationale for Development and What We Can
Expect for the Future." Drugs 56: 747-756, 1998.Allen, Theresa M. "Long-circulating (sterically stabilized) liposomes for targeted drug delivery ."
TiPs 15: 214-219, 1994.Allen, Theresa M. "Opportunities in Drug Delivery." Drugs 54 Suppl. 4: 8-14, 1997Janknegt, Robert. "Liposomal and Lipid Formulations of Amphotericin B." Clinical Pharmacokinetics.
23(4): 279-291, 1992. Kim, Anna et al. "Pharmacodynamics of insulin in polyethylene glycol-coated liposomes."
International Journal of Pharmaceutics. 180: 75-81, 1999.Quilitz, Rod. "Oncology Pharmacotherapy: The Use of Lipid Formulations of Amphotericin B in Cancer
Patients." Cancer Control.5:439-449, 1998. Ranade, Vasant V. "Drug Delivery Systems: Site-Specific Drug Delivery Using Liposomes as Carriers."
Pharmacology. 29: 685-694, 1989. Storm, Gert and Daan J.A. Crommelin. "Liposomes:quo vadi?" PSTT 1: 19-31, 1998. Taylor, KMG and JM Newton. "Liposomes as a vecicle for drug delivery." British Journal of Hospital
Medicine. 51: 55-59, 1994
![Page 31: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/31.jpg)
WebsitesJames, John S. "Doxil Approved for KS." www.immunet. org.imminet/atn.nsf/page/a-235-03.Wasan, Ellen. "Targeted Gene Transfer." Member.tripod.com/~rrishna/lipos1.html"Introduction to Controlled Drug Delivery Systems." www5.bae.ncsu.edu/bae/reearch/blak…
k/otherprojects/drugDeliver_97/http://www. Mssm.edu/medicine/thrombosis/phosphol.html"Doxorubicin." http://tirgan.com/adria.htm"Clinical Pharmacology Online." http://www.cponline.gsm.com/scripts/fullmono/showmono. "Drugstore.com" http://www.drugstore.com/pharmacy/prices/Amphotec."Sequus' Doxil Becomes First Liposome Product Approved In U.S." www.slip.net/~mcdavis/
database/doxor_1"Liposomes." www.collabo.com/liposom0.htmPaustin, Timothy. “Cellular Membranes.”www.bact.wisc.edu/microtextbook/bacterialstructure/Membranegen.htmlwww.cbc.umn.edu/~mwd/cell_www/chapter2/membrane.html#PHOSPHOLIPIDS
BooksJones, Macolm N. and Chapman, David. Micelles, Monolayers and Biomembranes. Wiley-Liss. New York (1995).
Garrett, R. and Grisham C. Biochemistry, 2nd ed. Saunders Colleges Publishing. New York (1999). 264.
![Page 32: Presentation1](https://reader035.fdocuments.us/reader035/viewer/2022070301/54545cf5af79599f308b49ec/html5/thumbnails/32.jpg)
Thank YouThank You